Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
4
×
boston top stories
life sciences
national blog main
national top stories
biotech
indiana blog main
indiana top stories
san francisco blog main
san francisco top stories
boston
boulder/denver blog main
boulder/denver top stories
clinical trials
deals
detroit blog main
detroit top stories
europe blog main
europe top stories
fda
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
sarepta therapeutics
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
aimmune therapeutics
allergy
alnylam pharmaceuticals
ambys medicines
amicus therapeutics
ampio pharmaceuticals
What
fda
4
×
therapy
4
×
approval
drug
gene
therapeutics
won
address
agency
aimmune
allergy
approved
approves
aren’t
awarded
betting
billion
bio
biopharma
blueprint
cancer
carries
certain
deal
designed
developed
developers
drugs
duchenne
friday
genetic
help
historic
imminent
immunotherapy
late
latest
long
medicare
medicine
Language
unset
Current search:
m
×
" boston blog main "
×
fda
×
therapy
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More